About Curepro Parenterals Limited
Data last updated:
Curepro Parenterals Limited was a public limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Aurobindo Pharma Ltd. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 April 2013.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2013PLC087101. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹20 Cr and a paid-up capital of ₹13.31 Cr. It was led by directors including Bhanu Murthy Chavali (Whole-Time Director) and Madan Mohan Reddy Mettu.
Its last annual general meeting (AGM) was held on 24 August 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at Plot No.2 Maitrivihar Ameerpet, Hyderabad, Telangana, India – 500038.
Its group structure included 1 subsidiary.
The company was associated with 1 brand: Aurobindo Pharma. Court records list 2 cases involving the company, including 2 filed by the company.
The last known website on record is aurobindo.com.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social Media
- Registered AddressPlot No.2 Maitrivihar Ameerpet, Hyderabad, Telangana, India – 500038
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Curepro Parenterals Limited
The main business activity of Curepro Parenterals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Curepro Parenterals Limited FY 2020 filings available
Financial Statement Summary of Curepro Parenterals Limited
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Curepro Parenterals Limited
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Curepro Parenterals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Curepro Parenterals Limited
Curepro Parenterals Limited is audited by G PAVAN KUMAR & ASSOCIATES for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| G PAVAN KUMAR & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Curepro Parenterals Limited
Curepro Parenterals has 4 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madan Mohan Reddy Mettu Also directs: MSS Packaging Industries LLP, Aurobindo Pharma Ltd, Engenra Biologics Private Limited and 5 more | Director | 21 Aug 2013 | 13 Years 1 Months | As last reported |
| Sivakumaran Meenakshisunderam Also directs: Curateq Biologics Private Limited, Eugia Steriles Private Limited, Tergene Biotech Limited and 3 more | Director | 25 Jun 2015 | 11 Years 3 Months | As last reported |
| Bhanu Murthy Chavali Also directs: Aurobindo Antibiotics Private Limited | Whole-Time Director | 27 May 2019 | 7 Years 4 Months | As last reported |
| Sarath Chandra Reddy Penaka Also directs: Aurobindo Pharma Ltd, Aurobindo Pharma Foundation, Sarath Penaka Enterprises LLP and 5 more | Director | 12 Sep 2013 | 13 Years 0 Months | As last reported |
Ownership and Shareholding of Curepro Parenterals Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Curepro Parenterals Limited
Curepro Parenterals Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Curepro Parenterals Limited
Curepro Parenterals Limited has 2 court cases on record: 2 filed by Curepro Parenterals. All cases are disposed. Status as checked between 30 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court for State of Telangana | Company petition | Filed by the company | Disposed |
| High Court for State of Telangana | Court case (COMPA) | Filed by the company | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Curepro Parenterals Limited
Curepro Parenterals operates one associated brand: Aurobindo Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Generic biocatalytic solutions are provided for pharmaceutical applications. | aurobindo.com |
Employees and EPFO Compliance at Curepro Parenterals Limited
Employment history and EPFO contributions of people linked to Curepro Parenterals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Curepro Parenterals Limited
Curepro Parenterals has 1 subsidiary company. This group structure data is as of FY 2019. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Eugia Pharma Specialities Limited | U24297TG2013PLC087048 | Locked |
Showing major subsidiaries. Total: 1.
CIN History of Curepro Parenterals Limited
Curepro Parenterals has one previous CIN (Corporate Identification Number): U24232AP2013PLC087101. The current CIN is U24232TG2013PLC087101, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2013PLC087101 | Current |
| U24232AP2013PLC087101 | Previous |
Recent Activity on Curepro Parenterals Limited
Curepro Parenterals Limited has 11 board changes on record since 2013: 4 appointments and 7 cessations. The latest: Bhanu Murthy Chavali was appointed as Whole-Time Director on 27 May 2019.
2 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Curepro Parenterals Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Curepro Parenterals Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Curepro Parenterals Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Curepro Parenterals Limited
Curepro Parenterals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Curepro Parenterals Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Curepro Parenterals Limited
Curepro Parenterals has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Curepro Parenterals was a public limited company based in Hyderabad, Telangana, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 19 April 2013 and is registered under CIN U24232TG2013PLC087101. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Curepro Parenterals was incorporated on 19 April 2013. It is registered with the Registrar of Companies, Hyderabad.
Curepro Parenterals had 4 directors:
- Bhanu Murthy Chavali - Whole-Time Director
- Madan Mohan Reddy Mettu - Director
- Sivakumaran Meenakshisunderam - Director
- Sarath Chandra Reddy Penaka - Director
The CIN (Corporate Identification Number) of Curepro Parenterals is U24232TG2013PLC087101. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Curepro Parenterals is at Plot No.2 Maitrivihar Ameerpet, Hyderabad, Telangana, India – 500038.
Curepro Parenterals can be reached through the website aurobindo.com. Its registered office is in Hyderabad, Telangana, India.
Curepro Parenterals has an authorised share capital of ₹20 Cr and a paid-up capital of ₹13.31 Cr.
No. Curepro Parenterals has 1 GST registration on record and it is cancelled or inactive.
Curepro Parenterals operated in the pharma industry, in the drug formulation and development segment.